Subscribe Login
Retail

AB Foods 'Not Worried' About Food Demand Impact Of New Weight-Loss Drugs

By Donna Ahern
AB Foods 'Not Worried' About Food Demand Impact Of New Weight-Loss Drugs

Penneys owner Associated British Foods (AB Foods), one of the world's biggest producers of bread, cereals and hot drinks, is not concerned about the impact on demand from new appetite-suppressing, anti-obesity drugs, its boss recently noted.

Walmart noted last month it was seeing a slight pullback in US food consumption when people took weight-loss drugs like Novo Nordisk's Wegovy, sparking a sell off in the shares of some food makers.

Leading Positions

Penneys owner AB Foods owns grocery brands with leading positions in markets across the globe.

These include Kingsmill bread, Jordans cereals, Twinings tea and Ovaltine drinks.

ADVERTISEMENT

It also owns major sugar, ingredients and agriculture businesses.

"We're not worried about volumes at all," AB Foods CEO George Weston told Reuters in an interview.

"We are not a business that thrives by selling more food, we try to premiumise, we try to trade people up, we try to offer better food than people might have eaten before," he said.

'Fairly Static'

Weston also noted that the population in most of its markets was fairly static and that a strategy of trying to sell increased volume would be hard to pull off.

ADVERTISEMENT

"Trading on trying to increase calories you sell, I think that hasn't been a good strategy for a long time," he said.

Last week, Sainsbury's, Britain's second biggest supermarket group, said it was too early to assess the impact on food demand of the new drugs but it was watching the issue 'very carefully'.

Read More: Penneys Owner AB Foods Expects Growth In New Year After Profit Rises 5%

News by Reuters, edited by Donna Ahern, Checkout. For more retail stories, click here. Click subscribe to sign up for the Checkout print edition.

Stay Connected With Our Weekly Newsletter

Processing your request...

Thanks! please check your email to confirm your subscription.